Bank of America
MAIA icon

Bank of America’s MAIA Biotechnology MAIA Stock Holding History

Bank of America’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30
Closed -$46 – 6405
2025
Q4 		$46 Buy
30
+1
+3% +$1 ﹤0.01% 6973
2025
Q3 		$45 Sell
29
-202
-87% -$330 ﹤0.01% 8037
2025
Q2 		$416 Buy
231
+52
+29% +$93 ﹤0.01% 7705
2025
Q1 		$274 Buy
179
+15
+9% +$28 ﹤0.01% 7625
2024
Q4 		$325 Buy
164
+8
+5% +$19 ﹤0.01% 7493
2024
Q3 		$438 Buy
156
+19
+14% +$59 ﹤0.01% 7406
2024
Q2 		$469 Buy
+137
New +$432 ﹤0.01% 7374
2024
Q1 		– Sell
-8
Closed -$9 – 8010
2023
Q4 		$9 Buy
+8
New +$13 ﹤0.01% 7793
2023
Q1 		– Sell
-2
Closed -$7 – 8082
2022
Q4 		$7 Buy
+2
New +$7 ﹤0.01% 8114

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America's MAIA Position: Q1 2026 in Review

Bank of America sold out of MAIA Biotechnology (MAIA) in Q1 2026, closing a stake of 30 shares — an estimated $46 sold.

Bank of America first reported a position in MAIA in Q4 2022 and held it in 9 quarters. The position peaked at $469 in Q2 2024. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Bank of America reported no remaining MAIA Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 30 MAIA Biotechnology shares in Q1 2026, an estimated $46.
  • Bank of America first reported a position in MAIA Biotechnology in Q4 2022 and held it in 9 quarters.
  • Bank of America's MAIA Biotechnology position peaked at $469 in Q2 2024.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.